RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: Distinguishing infiltrative renal cell carcinoma (RCC) from transitional cell carcinoma (TCC) is a challenging issue due to their radiologic similarities. We evaluated systemic inflammatory biomarkers as parameters for distinguishing tumor types.
Materials and Methods: A computerized search of medical records from November 2005 to October 2015 identified 116 patients with infiltrative renal masses who were difficult to diagnose confirmatively in radiological study. We investigated the diagnostic efficacy among these patients with their preoperative absolute neutrophil counts (ANC), absolute lymphocyte counts (ALC), absolutemonocyte counts (AMC), neutrophil-lymphocyte ratio (NLR), and lymphocyte-monocyte ratio (LMR).
Results: The infiltrative RCC group demonstrated significantly lower ALC {1449/μL (1140–1896), median [interquartile range (IQR)]} than the TCC group [1860/μL (1433–2342), p=0.016]. LMR [median (IQR)] also was lower in the infiltrative RCC group [2.98 (2.32–4.14) vs. TCC group 4.10 (2.86–6.09); p=0.011]. In subgroup analysis, non-metastatic infiltrative RCC showed lower ALC and LMR and higher NLR than non-metastatic TCC. Within non-metastatic infiltrative renal masses, multivariate logistic regressionanalysis revealed that younger patient age and lower LMR were associated with infiltrative RCC [odds ratios (OR) 0.874, p=0.024 and OR 0.461, p=0.048, respectively]. Receiver operating characteristic curve analysis showed that younger age and lower LMR were highly predictive of non-metastatic RCC (area under the curve=0.919, p<0.001).
Conclusion: Age and LMR were significantly different between patients with infiltrative renal mass. These are potential markers for distinguishing between infiltrative RCC and TCC without metastasis.

번역하기

참고문헌 (Reference)

1 Dalpiaz O, "Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma" 110 : 2531-2536, 2014

2 Pichler M, "Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients" 108 : 901-907, 2013

3 Dalpiaz O, "Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma" 114 : 334-339, 2014

4 Bata P, "Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CT" 55 : 1112-1119, 2014

5 Chang Y, "Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma" 113 : 626-633, 2015

6 Luo HL, "Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome" 113 : E144-E14*, 2014

7 Mantovani A, "Role of tumor-associated macrophages in tumor progression and invasion" 25 : 315-322, 2006

8 Li Y, "Renal cell carcinoma growing into the renal pelvis and mimicking transitional cell carcinoma: a case report and literature review" 9 : 1869-1872, 2015

9 Keskin S, "Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma" 14 : 95-, 2014

10 Chang Y, "Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma" 37 : 4613-4620, 2016